MIKAN GEORGE LAWRENCE III (CEO & President) sold 13.3% of their position (28.26K shares) of NEUEHEALTH, INC. on the open market
Open‑market sale worth $203.0K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 3/11/2025ACC: 0001628280-25-012195
DirectorOfficer· CEO & President
Since Jun 2021
-28.26K
Net shares
Net seller
$203.0K
Total sold
2
Open market trades
0B · 2S
4
Total transactions
7.57K acquired · 35.83K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−26.66K
Price / share
$7.19
Trade value
$191.69K
% of position
13.0%
3/7/2025
205.42K→178.76K
Common Stock
Direct
Shares
+7.57K
Price / share
—
Trade value
—
% of position
4.2%
3/7/2025
178.76K→186.32K
Common Stock
Direct
Shares
−1.60K
Price / share
$7.06
Trade value
$11.32K
% of position
0.9%
3/10/2025
186.32K→184.72K
Total
Net shares
−20.70K
Net value
-$203.01K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/7/2025 | S · Sale | −26.66K | $7.19 | $191.69K | 13.0% | 205.42K | 178.76K |
| Common Stock Direct | 3/7/2025 | M · Option Exercise | +7.57K | — | — | 4.2% | 178.76K | 186.32K |
| Common Stock Direct | 3/10/2025 | S · Sale | −1.60K | $7.06 | $11.32K | 0.9% | 186.32K | 184.72K |
| Total | −20.70K | -$203.01K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
7.57K shares
Shares
−7.57K
Strike price
Held after
0.00
Exercisable
—
3/7/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock7.57K shares | 3/7/2025 | M · Option Exercise | −7.57K | — | 0.00 |